Zeco Auriemo: Brazil’s Game Changer in Real Estate

José Auriemo Neto commonly known as Zeco is a leader who grew up in a family that was already deep in the real estate business. However, Zeco did not leave the family name during his day-to-day business, and it’s for that reason that his successes or rather the success of JHSF are attributed.

While still in his adolescence, Zeco Auriemo began to work under his father’s mentorship at JHSF, a family-owned company. As a result of this early witnessed commitment, by the age of 30, Zeco was already at the realm of leadership in the company, where he serves as the CEO and chairman to date.

Under his leadership, JHSF is now an internationally recognized company, and in the recent past, the firm acquired a permit to upgrade a property in the heart of New York, 5th avenue. That’s only but a tip of the iceberg, as Zeco, who has a niche for luxury is slowly changing the scenes of Brazil’s real estate enterprise.

Zeco Auriemo has spearheaded several game-changing projects in Brazil. The badges on his suit include the popular Cidade Jardim Corporate Center, a complex with 180 floors that comprise of offices and apartments. In addition to this gem, Mr. Zeco has invested in various shopping malls including Metro Santa Cruz and Metro Tucuruvi.

José Neto‘s commitment to investing is unparalleled, and so is his love for charity. Mr. Auriemo recognizes the role of his kindness toward giving back to the community and heeds to this call. Several charities and community development programs have been able to receive handsomely from this philanthropist. All his plans and visions begin and end with family. Zeco Auriemo is a dedicated husband to Mariana Landmann Auriemo, and a loving father of two children whom he mentors to achieve greatness, visit http://netnoticia.com.br/2018/01/18/saiba-a-razao-de-jose-auriemo-neto-ser-considerado-o-rei-da-incorporacao-de-luxo/.

The RealReal’s Instagram Page Is More Educational Than You Think

The RealReal has grown into a trillion dollar business since its launch. This online consignment shop wants to share the life of luxury with its customers. They also want to revitalize the consignment industry one brand at a time. Owner and founder Julie Wainwright started her business outside of her home, which then became a brick-and-mortar store.

Since then, it’s become the ultimate site for luxury consignment shopping. The RealReal has earned over $1.5 trillion dollars, has hired over 600 employees, and has various locations across the U.S. that even ship products worldwide. The RealReal makes sure that everything they sell is authentic. That’s why they teamed up with a group of gemologists, authentication experts, and horologists.

They teach their shoppers how to look for authentic designer pieces as well. They learned how to tell the difference between real and counterfeit, which includes the detail of the hardware to the quality of the leather. Take this Instagram post which shows a ridiculous pair of hooped pearl earrings, but for good reason. The brand wants you to see the quality and detail up close. They claim these pearl earrings are more for the modern girl.

Then there are simple posts like this one of a green leather handbag. If you play the video, you’ll see a leopard print hat, a silver boot, and a pair red of sunglasses fall out of the sky and onto the bag. Each of these items is designer pieces that are available on The RealReal.

Pharmaceutical Mogul Jeffrey Aronin Champions Porphyria When No One Else Would

In America’s profit driven pharmaceutical industry, life-saving treatments can find themselves can find themselves at risk of extinction if they become too costly to manufacture. Treatments for rare disorders are especially at risk, as the pool of “customers” is already a small one. Too many treatments have disappeared because of a slim profit margin or expensive production methods, leaving suffering patients to make due with less effective treatments that are more easily mass-produced. Thanks to one man, the story is different for thousands of people across the country.

 

When Jeffrey Aronin found out that a medicine called Panhematin was being discontinued by its manufacturer, he jumped into action. Panhematin is one of the only available treatments for the disease family called porphyria, which is caused by a build-up of natural chemicals in the body and whose symptoms range from debilitating to deadly. Porphyria at its worst can manifest as seizures, paralysis, permanent nerve damage, and even lead to comas. Panhematin was already being championed by the American Porphyria Foundation, but there were less than one hundred vials available after production had halted months prior.

 

Aronin quickly became the driving force behind the movement to save Panhematin. Under his own pharmaceutical company Ovation he ran trials, found hundreds of participants, and took over marketing and awareness for both disease and treatment. Eventually it passed through the ownership of a few other pharmaceutical companies before finding a permanent home with Recordati Rare Diseases Group. Through his dedication and hard work Panhematin once again became a commercially viable product, and is still available to this day.

 

Most Americans will never hear about porphyria. Even fewer will have to deal with the pain and suffering that become a part of every day life when dealing with porphyria. But for those who do, the difference between how they manage their condition now and what their lives would look like if Jeffrey Aronin hadn’t stepped in is immeasurable.

 

Marathon Pharma Improves The Injection Process

Medicine has certainly come a long way in recent years. Diseases that were once death sentences are now just an inconvenience. While most of the world’s worst diseases still haven’t been cured, much progress has been made in the treatment department. It is now much easier for people with serious medical conditions to live healthy and more-or-less normal lives. We have many fine scientists and doctors to thank for these advancements, as no one would dispute. But in all fairness, we should give a little credit to the pharmaceutical companies as well.

 

It has become fashionable for people to badmouth “big pharma,” and in some cases, this attitude may even be justified. However, it is only fair to give these companies and their people credit for the large amount of good work that they have done in advancing the treatment of various diseases and conditions. One company that has really done a lot in the research department is Marathon Pharmaceuticals.

 

For all our advancements, we still haven’t moved past certain primitive methods. The injection has been a popular method of delivering medicine to a patients bloodstream for many years. The subcutaneous injection, as we know it today, was invented in the year 1844 by an Irish doctor named Francis Rynd. Isn’t it strange that this method is still so common? You would think that someone would have at least improved the process by now!

 

A company called Marathon Pharmaceuticals has done exactly that. Their new product, called Zingo, is mainly intended for children who regularly require injections of medicine to deal with their conditions. While an adult may not think much of the minor pain of an injection, a child tends to be much less able to tune out the pain.

 

Zingo is a new type of local anesthetic based on a lidocaine mixture. It is applied to the injection site so as to numb the area. While the use of local anesthetics is not new, it was not practical in the past to use them on something as minor as a routine injection. Not only have they come up with a new formula, but Marathon has also found ways to produce this medicine at a price that anyone can afford.

 

Jeff Aronin: Biosciences Innovator

Jeff Aronin, the Chairman and CEO of Paragon Biosciences, has found the secret to success. By combining a passion with his work, Aronin is changing the lives of those suffering with severe conditions every day. Recently named as one of the 20 most influential leaders in the healthcare field for 2018, Aronin is a leading industry executive in highly competitive and innovative healthcare field. (insightscare)

Aronin’s company has found an unique niche in the healthcare field. The portfolio companies Paragon Biosciences manage work to find solutions to diseases that are typically under served by the pharmaceutical and healthcare industries. Instead of focusing on issues effecting wide sections of the population, Aronin’s companies focus on rare conditions that most companies ignore. This has led to the treatments developed having a large impact on the daily lives of those who traditionally have not been addressed by the healthcare industry at large.

Perhaps most telling of Aronin’s success as a leader is not the 32 novel and new drug approvals that have been earned by Aronin’s team, but the fact that Aronin is someone who people want to work for and continue to work for. Inspired by his vision and leadership, many of those on Aronin’s staff have been with his team for over 15 years. This speaks volume to Aronin as a leader as his staff continue to support and implement his vision.

In the past year, Paragon has invested over $450 million and will be investing an additional $445 million in capital over the next 12 months to continue researching and developing innovative treatments that address these conditions that are not typically researched. The patients first priority exemplified by Aronin, and by extension Paragon, is dramatically impacting people’s lives who are typically lost in the healthcare system. The impact that one company can have on the lives of individuals is seen with each new drug Paragon receives approval for. While smaller populations may be impacted than those researched by many other companies, the impact on life improvement for those suffering cannot be underestimated.

 

How Bernardo Chua Built A Global Brand In The Beverage Industry

Bernardo Chua is an entrepreneur in the beverage industry. He is the founder of Organo Gold and its chief executive officer. His company sells coffees and teas with a twist; they contain a ground mushroom called Ganoderma Lucidem which is believed to be very healthy to consume.

His company’s products are sold through network marketing. This means that they are sold to independent distributors who then sell the products themselves to their customers, earning a commission on every sale. He has independent distributors in the United States, Canada, and overseas in several nations. Visit on his twitter for latest updates.

He is originally from the Philippines. After growing up there, Bernardo Chua joined his family’s business. The big problem he had there, as he relates, is that many of his older brothers, sisters, and cousins also worked there and for a longer time than him. This meant that he had “many bosses” as he puts it. This was the impetus to develop into a businessman.

After leaving the family business he joined Gano Excel. This was his first experience in the beverage industry and he did very well as its general manager. His hard work led to this company extending its operations across Southeast Asia. When his company decided to enter the North American Market he moved to the United States and established its subsidiary, Gano Excel USA.

It was in 2008 that he established Organo Gold, headquartered in Richmond, BC. He started with just a few employees and just ten years later his company is one of the world’s leading providers of instant coffee. he says that starting his company during the recession led to some difficulties in its early years but as the global economy improved so did his business’ prospects. He has had his company named as the Direct Sales Company of the Year five times now.

Learn more: http://centraljerseyworkingmoms.com/bernardo-chua-motivates-retail-customers-and-distributors-with-new-rewards-program/

 

Sandy Chin Recently Shared Strategies and Business Ideas For Young Entrepreneurs To Follow Up

For 20 years Sandy Chin has been covering consumer staples and in 2016, she founded Tidal Bore Capital which is a staple focused hedge fund. She was a portfolio manager at Visium Asset Management prior to founding the hedge fund. For two years, Sandy has been involved with SAC Capital Management and worked there as an analyst.

 

Before she started her career working for her mentor, Sandy worked at the Bank Of America and Donaldson, Lufkin & Jenrette. She did her BA in political science from Barnard College and earned an MBA from Stern School of Business, New York University.

 

Recently in an interview, she discussed her strategies and learnings from her experience in the industry. Sandy recalled how she skipped law school after majoring in Political Science. In that period of time, she was hired by Donaldson, Lufkin & Jenrette which is a sell-side research firm and later worked with her mentor for the next ten years. When asked about the current trend that excites her, she was prompt to say the signs of cannabis legalization in the staples arena was an interesting fact to her.

 

She discussed the strategy which helped her expand the business. Sandy claimed that she never turned down a meeting irrespective of the designation or the urgency. She insists the young entrepreneurs perceive and analyze every opportunity that presents itself and to finally make the most out of it. As an entrepreneur, she believes failures are inevitable and need to be overcome at any cost. She admits that the excessive exposure to a sub-sector in her industry took a hit on her portfolio.

 

Lastly, she was asked to share a business idea she would want entrepreneurs to make something out of. Her idea of an app integrated dog rental service for scheduling the dog for peak walk times thus lowering the burden on the owner.

 

Sandy Chin claims to have trained her mind to comprehend information faster and accurately by capitalizing the exposure to just one sector for a period of 20 years. This ability helps her to make critical decisions for consumer staples.

 

 

 

 

https://www.linkedin.com/in/sandy-chin-651127a4

Matt Badiali contributions as an investor

Matt Badiali is a prolific investor. His investment analysis is based on the knowledge he has about the mining sector. He can get opportunities when others are getting none. He has a reputation in the industry for helping the average and the less skilled investor learn how to make correct predictions. He is taking as much time as possible to transform the industry into something better. He joined the investment sector a few decades ago, and now he is doing a great job of facilitating the culture of investment in the country. Many people who have followed his advice has seen good results.

Matt Badiali has a degree from Earth Science from Penn State University and masters degree in Geology From Atlantic University. He has been to countries around the world, visiting mining fields to understand how the mining operations in these countries look like. He has also worked with other people, many of them CEOs in mining companies. He has always wanted to know what is going on in the mining sector so that he can be in a better position to guide his followers. In the time that he has been in the industry, he has made sure that the operations of the mining sector are keenly monitored for investment opportunities. As an educated geologist, Matt Badiali does his own analysis and does not need any help to analyze mining data. Every decision he makes is done based on analysis and not what someone else has proposed.

Matt Badiali has built a stable career by helping the average person to benefit from Matt Badiali’s knowledge. He is generous with information and believes that the average investor can create wealth by following his advice. Looking back at the way he has been doing business, it is right to say that he has done a great job. Some of the ideas he has proposed of great value to investors. The idea of Freedom Checks is one of those which he has introduced this year. Freedom Checks is an idea which involves people investing in businesses that are given tax exemptions under Statute 26-F of the internal revenue regulations.

The Brilliant Move by Madison Street Capital to Recruit Lawrence Alioto as the Managing Director

Over the past few decades, Madison Street Capital has been at the forefront in the quest for the provision of quality services to the clients of the financial and investment sector. As a banking and investment advisory firm, it has been quite vibrant in helping its clients to offer excellent services to their customers so that they can improve the level of customer satisfaction and also the reputation of the financial sector of the economy. Most of its clients are the middle-class financial institutions that require consultancy services regarding corporate financing, the management of mergers and acquisitions, financial planning, maintenance of integrity and other ethics of the business.

 

Recently, Madison Street Capital, under the leadership of its able president, Mr. Charles Botchway, announced the joining of a new Managing Director into the company’s team. Lawrence, Alioto was the preferred candidate for the position due to his vast experience in the primary functions that are performed by Madison Street Capital. Upon receiving the news, the team of employees at Madison Street Capital was very excited since they understood the level of proficiency and professionalism of the new member. The clients were also poised by the management’s decision to recruit Lawrence as their new chief adviser since they knew very well his capabilities in the role that was before him.

 

There are several attributes that qualified Lawrence as the best candidate for the position of the Managing director of Madison Street Capital. One of the qualifications was his vast experience in the management of mergers and acquisitions. In the current market conditions, M&A has become an integral part of many businesses in their quest for new business opportunities. However, many organizations lack the capacity to effectively manage these entities due to lack of the expertise. As one of the primary services offered by Madison Street to its clients, the company needed the most proficient person who could provide the perfect advice to their clients for the same area. Lawrence Alioto happened to have the best fit qualifications since he has a working record of merging and overseeing a myriad of purchases of businesses in the industry.

 

His aptitude in the technology and the emerging issues in the sector was also another aspect that lured the interviewers to recruit Lawrence into Madison Street Capital. This was because he had an extensive experience in a technology-related firm where he worked for more than three years. His record while running the firm was excellent and so they were convinced that he would translate the same excellence to Madison Street Capital. Corporate Financing was also another area that Lawrence showed expertise. With a long working experience with the largest banking and investment organizations in the region, he has managed to grasp the required skills that he will impart to the clients of Madison Street Capital.

 

Visit http://madisonstreetcapital.org/ to learn more.